• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

犬和猴静脉推注给药后血浆纳曲酮的动力学

Plasma naltrexone kinetics after intravenous bolus administration in dogs and monkeys.

作者信息

Reuning R H, Batra V K, Ludden T M, Jao M Y, Morrison B E, McCarthy D A, Harrigan S E, Ashcraft S B, Sams R A, Bathala M S, Staubus A E, Malspeis L

出版信息

J Pharm Sci. 1979 Apr;68(4):411-6. doi: 10.1002/jps.2600680405.

DOI:10.1002/jps.2600680405
PMID:108382
Abstract

This investigation generated data characterize a specific electron-capture GLC assay reported previously for naltrexone and applied the method to a determination of naltrexone pharmacokinetics. Extraction efficiencies are reported for the assay, and mass spectral evidence indicates that naltrexone forms a triester when derivatized for electron-capture GLC with pentafluoropropionic anhydride and a base catalyst. Plasma level-time data for intravenous naltrexone at two dose levels in monkeys yielded no evidence of dose-dependent kinetics. A two-compartment open pharmacokinetic model was fitted to plasma level-time data for naltrexone in two dogs and yielded a total body clearance of 51-55 ml/min/kg. Urine collected for 0-24 hr contained 36% of the dose as naltrexone conjugates with less than 1% as unchanged naltrexone. Plasma level-time data for intravenous naltrexone in six monkeys yielded an average terminal half-life of 7.8 hr and a total body clearance of 64 ml/min/kg. The total body clearance for naltrexone was greater than the hepatic plasma or blood flow in both dogs and monkeys. This finding, together with the extremely low renal excretion of naltrexone, suggests the existence of elimination mechanisms besides liver metabolism and renal excretion.

摘要

本研究生成了表征先前报道的用于纳曲酮的特定电子捕获气相色谱分析的数据,并将该方法应用于纳曲酮药代动力学的测定。报告了该分析的提取效率,质谱证据表明,纳曲酮在用五氟丙酸酐和碱催化剂进行电子捕获气相色谱衍生化时形成三酯。猴子静脉注射纳曲酮在两个剂量水平下的血浆浓度-时间数据未显示剂量依赖性动力学的证据。对两只狗体内纳曲酮的血浆浓度-时间数据拟合二室开放药代动力学模型,得出总体清除率为51 - 55 ml/min/kg。收集的0 - 24小时尿液中,36%的剂量为纳曲酮缀合物,未变化的纳曲酮含量低于1%。六只猴子静脉注射纳曲酮的血浆浓度-时间数据得出平均终末半衰期为7.8小时,总体清除率为64 ml/min/kg。在狗和猴子中,纳曲酮的总体清除率均大于肝脏血浆或血流。这一发现,连同纳曲酮极低的肾排泄率,表明除肝脏代谢和肾排泄外,还存在其他消除机制。

相似文献

1
Plasma naltrexone kinetics after intravenous bolus administration in dogs and monkeys.犬和猴静脉推注给药后血浆纳曲酮的动力学
J Pharm Sci. 1979 Apr;68(4):411-6. doi: 10.1002/jps.2600680405.
2
Naltrexone disposition in man after subcutaneous administration.皮下注射后纳曲酮在人体内的处置情况。
Drug Metab Dispos. 1984 Nov-Dec;12(6):677-82.
3
The seminal excretion, plasma elimination, tissue distribution and metabolism of naltrexone in the rabbit.纳曲酮在兔体内的精液排泄、血浆消除、组织分布及代谢
J Pharmacol Exp Ther. 1980 May;213(2):289-99.
4
Kinetics of a naltrexone sustained-release preparation.纳曲酮缓释制剂的动力学
Clin Pharmacol Ther. 1984 Nov;36(5):704-8. doi: 10.1038/clpt.1984.243.
5
Metabolism and disposition of naltrexone in man after oral and intravenous administration.
Drug Metab Dispos. 1981 Jul-Aug;9(4):369-75.
6
Overview of human pharmacokinetics of naltrexone.纳曲酮的人体药代动力学概述。
NIDA Res Monogr. 1981;28:161-71.
7
Pharmacokinetics of morphine and its surrogates V: Naltrexone and naltrexone conjugate pharmacokinetics in the dog as a function of dose.
J Pharm Sci. 1985 Jan;74(1):50-6. doi: 10.1002/jps.2600740114.
8
Determination of naloxone and naltrexone as perfluoroalkyl ester derivatives by electron-capture gas-liquid chromatography.通过电子捕获气液色谱法测定纳洛酮和纳曲酮的全氟烷基酯衍生物。
J Chromatogr. 1976 Oct 13;125(2):409-20. doi: 10.1016/s0021-9673(00)83372-5.
9
An electron-capture gas chromatographic assay for naltrexone in biological fluids.生物流体中纳曲酮的电子捕获气相色谱测定法。
NIDA Res Monogr. 1981;28:25-35.
10
Pharmacokinetic properties of ethosuximide in monkeys. I. Single-dose intravenous and oral administration.乙琥胺在猴体内的药代动力学特性。I. 单剂量静脉注射和口服给药。
Epilepsia. 1975 Dec;16(5):705-16. doi: 10.1111/j.1528-1157.1975.tb04755.x.

引用本文的文献

1
Effects of Δ⁹-tetrahydrocannabinol (THC), cannabidiol (CBD), and THC/CBD mixtures on fentanyl versus food choice in rhesus monkeys.Δ⁹-四氢大麻酚(THC)、大麻二酚(CBD)及其混合物对恒河猴选择芬太尼与食物的影响。
Drug Alcohol Depend. 2023 Mar 1;244:109787. doi: 10.1016/j.drugalcdep.2023.109787. Epub 2023 Feb 1.
2
Disposition of naltrexone after intravenous bolus administration in Wistar rats, low-alcohol-drinking rats and high-alcohol-drinking rats.静脉推注纳曲酮后在Wistar大鼠、低酒精摄入大鼠和高酒精摄入大鼠体内的处置情况。
Neuropsychobiology. 2008;58(2):81-90. doi: 10.1159/000159776. Epub 2008 Oct 3.
3
Pharmacokinetic quantitation of naltrexone controlled release from a copolymer delivery system.
从共聚物给药系统中释放的纳曲酮控释的药代动力学定量分析。
J Pharmacokinet Biopharm. 1983 Aug;11(4):369-87. doi: 10.1007/BF01058956.
4
Possible mediation of catecholaminergic pathways in the antinociceptive effect of an extract of Cannabis sativa L.大麻提取物镇痛作用中儿茶酚胺能途径的可能介导作用
Psychopharmacology (Berl). 1986;89(2):244-7. doi: 10.1007/BF00310637.